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Objective: To identify the changes in the proteome of U937 cells infected with dengue
virus (DENV).
Methods: In this study, differentiated U937 cultures were infected with two DENV-2
strains, one of which was associated with dengue (DENV-2/NG) and the other one
with severe dengue (DENV-2/16681), with the aim of determining the cellular proteomic
proﬁles under different infection conditions. Cellular proteins were extracted and sepa-
rated by two-dimensional electrophoresis, and those proteins with differential expression
proﬁles were identiﬁed by mass spectrometry. The obtained results were correlated with
cellular viability, the number of infectious viral particles, and the viral DNA/protein
quantity.
Results: In comparison with non-infected cultures, in the cells infected with the DENV-
2/NG strain, nine proteins were expressed differentially (ﬁve were upregulated and four
were downregulated); in those cultures infected with the DENV-2/16681 strain, six
proteins were differentially expressed (two were downregulated and four were upregu-
lated). The downregulated proteins included fatty acid-binding protein, heterogeneous
nuclear ribonucleoprotein 1, protein disulﬁde isomerase, enolase 1, heat shock 70 kDa
protein 9, phosphotyrosyl phosphatase, and annexin IV. The upregulated proteins
included heat shock 90 kDa protein AA1, tubulin beta, enolase 1, pyruvate kinase,
transaldolase and phospholipase C-alpha.
Conclusions: Because the monocyte/macrophage lineage is critical for disease patho-
genicity, additional studies on these proteins could provide a better understanding of the
cellular response to DENV infection and could help identify new therapeutic targets
against infection.1. Introduction
Dengue is the most common disease in humans that is
transmitted by arthropods. It is caused by the dengue virus
(DENV) [1], which is transmitted by the bite of infected
mosquitoes, principally those of the species Aedes aegypti andAedes albopictus [2]. This virus, whose genome is made up of
positive-strand RNA, belongs to the Flaviviridae family and
the Flavivirus genus [3]. Although, in general, the existence of
four serotypes that share antigenic similarities but are
genetically different has been reported in the urban viral cycle
setting (DENV-1 to DENV-4), the existence of a ﬁfth sero-
type has recently been reported (DENV-5) in a wild cycle
setting [4].
Dengue affects the populations of tropical countries, where
more than 2500 billion people are at risk of being infected, and
it is endemic in over 100 of these countries [5]. Its prevalence has
increased dramatically in the last few decades, and recent studies
estimate that 96 million cases occur on a yearly basis, although
this number may be underestimated in some regions due to pooricle under the CC BY-NC-ND license (http://
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self-limiting febrile illness characterized by headaches, muscle
aches, and skin eruptions. The most severe form of the disease is
known as severe dengue in which there is increased vascular
permeability that results in plasma leakage; other symptoms
include thrombocytopenia, hemorrhagic manifestations, and
compromised organs, such as the liver, heart, and central ner-
vous system [6].
Although the pathogenesis of severe dengue is not
completely clear, some of the risk factors involved in its
development have been described (some related to the host and
some to the virus). Of the factors related to the virus, it has been
reported that the viral genetic variations partly determine viru-
lence and, therefore, epidemic potential [7], which allows certain
strains with higher replicative potential to spread more easily in
a primary infection. In addition, some serotypes and strains have
been associated with the development of severe forms of the
disease [8]. In this regard, some DENV strains within serotype
2 have been reported to be associated with the development of
mild or severe forms of the disease, as is the case for the New
Guinea strain (DENV-2/NG) (originally isolated from a
dengue patient) [9], and the DENV-2/16681 strain (isolated
from a patient with severe dengue) [10]. Based on their origin and
etiology, the DENV-2/NG strain has been associated with the
development of dengue [11], and the DENV-2/16681 strain has
been associated with severe dengue [12]. Regarding host-
associated factors, much has been discussed regarding the
pathogenic role of the immune response to a secondary infec-
tion. In this regard, the principles of antibody-dependent
enhancement and original antigenic sin are the most studied
[13,14]. Independent of the factors favoring the development of
severe dengue, whether in a primary or secondary infection,
there are some cells that play a very important role in the
initial capture of the virus, its transport to speciﬁc sites within
the host, and its replication and propagation.
Monocytes, macrophages, and dendritic cells are considered
the primary targets of DENV infection in vivo [15,16], although the
presence of the virus in different cell types such as hepatocytes,
lymphocytes, endothelial, epithelial, neuronal, and muscle cells
has also been reported [17]. The monocyte/macrophage lineage,
which is normally involved in the processes of the innate and
adaptive immune responses, is successful in the elimination of
most pathogens, although pathogens sometimes use this
strategy to their advantage. In the case of dengue, macrophages
are not only the main targets of DENV for its replication but
also responsible for spreading the virus to different parts of the
hosting organism after its transmission and for enhancing
proinﬂammatory cytokine production, responsible in great
measure for the development of severe dengue [15,18]. Within
this lineage, the U937 cell line has been widely used to study
different aspects of DENV infection.
The U937 cell line, isolated from human histiocytic lym-
phoma, shows characteristics of immature monocytes, but its
differentiation promoted with phorbol esters converts it to a cell
line with the morphologic and functional characteristics of
macrophages [19]. This cell line can be infected with DENV by
two different mechanisms: through cell surface receptors (heat
shock 70 kDa protein and heat shock 90 kDa protein), thus
allowing the study of conventional forms of viral entry into
the host cell during primary or secondary infection, and
through Fc receptors that bind viral complexes with antibodies
during secondary infections [20,21]. This cell line has beenused for studies on viral replication [22], on the evaluation of
antiviral agents [23–25], on the immune response [26], etc.
Despite the importance and broad use of the U937 cell line,
no studies have been performed in which protein expression
changes have been determined in this cell line when infected by
DENV. For this reason, the present study identiﬁed the modi-
ﬁcations in the U937 proteome after infection with two strains of
DENV-2 clinically associated with dengue: the New Guinea
strain DENV-2/NG (associated with dengue) and the DENV-2/
16681 strain (associated with severe dengue) under primary
infection conditions.
2. Materials and methods
2.1. Cell maintenance and viral stock production
Differentiated-U937 cells (human monocyte derived from
lymphoma), and C6/36HT cells (derived from Aedes albopictus)
were a kind gift from Dr. Jaime E. Castellanos at the El Bosque
University (Bogota´, Colombia) and Dr. Guadalupe Guzman at
the Pedro Kouri Institute (Havana, Cuba). Both cell lines were
grown in Dulbecco's modiﬁed Eagle medium (Gibco/Invitrogen,
Grand Island, NY, USA) supplemented with 0.25 mg/mL of
amphotericin B, 100 mg/mL streptomycin, 100 units/mL peni-
cillin, and either 2% (U937 cells) or 10% (C6/36HT cells) fetal
bovine serum (FBS, Gibco). Cell cultures were incubated with
5% CO2, at either 37 C (U937 cells) or 34 C (C6/36HT cells).
For all assays, two serotype 2 reference strains were used: strain
DENV-2/NG (dengue reference strain) and strain DENV-2/
16881 (severe dengue reference strain). Both strains were a
kind gift from Dr. Jorge Osorio at the University of Wisconsin
(Madison, WI, USA). The viral stocks were expanded in the C6/
36HT cell line (ﬁve passages for each viral strain) and stored
at −70 C until used.
2.2. MTT viability assay
A colorimetric MTT assay was used to measure the effect of
the infection on U937 cell viability. For this assay,
2.5 × 104 cells were seeded in 96-well plates and were infected
[multiplicity of infection (MOI): 1] at 24 h. The infected cells
were incubated for an additional 48 h. Then, 50 mL of MTT
(0.5 mg/mL) were added, and the cultures were incubated for
3 h at 37 C. Then, 100 mL of dimethyl sulfoxide (Fisher Sci-
entiﬁc Inc., Rockford, IL, USA) were added, and the absorbance
was read at 450 nm using a Varioskan Flash reader (Thermo
Scientiﬁc Inc., Rockford, IL, USA). The data were processed by
comparing the absorbance of the infected cultures with the
absorbance of the uninfected control cultures. The results were
expressed as the mean of at least three independent experiments,
each with two replicates (n = 6).
2.3. Cell infection
A total of 3 × 106 U937 cells were seeded in 25 cm2 cell
culture ﬂasks. After 24 h, the cultures were incubated with each
of the reference stocks (DENV-2/NG or DENV-2/16681) for
2 h at 37 C at an MOI of 1. Afterwards, the virus was removed,
and the cultures were cultured for an additional 48 h, after which
the supernatant of each culture was collected and stored
at −70 C for subsequent infectious viral particle quantitation
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genome quantitation (by real-time RT-PCR) and for protein
extraction. There were ﬁve replicates of each experimental
condition (DENV-2/NG- or DENV-2/16681-infected cultures),
as well as ﬁve replicates for the uninfected control cultures.
2.4. Fluorescence microscopy
U937 cells were grown on glass coverslips at a density of
2.5 × 104 cells per coverslip and infected with DENV-2/NG or
DENV-2/16881 at a MOI of 1. At 48 h after inoculation, cell
monolayers were washed with phosphate buffered saline (PBS)
and ﬁxed with 3.8% paraformaldehyde in PBS at 37 C for
30 min. The monolayers were permeabilized with 0.5% Triton
X-100, blocked with 5% FBS and incubated with primary anti-
DENV antibody (1:500) followed by incubation with anti-mouse
secondary antibody conjugated with ﬂuorescein isothiocyanate
and Hoechst 33258 dye. Finally, the cells were washed with
PBS and the coverslips were mounted. Images were obtained
using an inverted microscope (IX-81 Olympus).
2.5. Viral quantitation by the plaque method
A total of 5 × 104 U937 cells were seeded in 24-well plates.
After 24 h, the cells were inoculated with 200 mL serial dilutions
(1 × 10−1 to 1 × 10−5) of collected previously viral supernatants.
After 2 h of incubation, the virus was removed and Dulbecco's
modiﬁed Eagle medium was supplemented with 2% FBS, and
1.5% carboxymethyl cellulose (Sigma–Aldrich, St. Louis, MO,
USA) was added. The plates were incubated for 8 days at 37 C
and 5% CO2. Then, the monolayers were ﬁxed with 4% para-
formaldehyde (Sigma–Aldrich) and stained with a crystal violet
solution (Sigma–Aldrich). The plaques were counted to deter-
mine the plaque-forming units (PFU/mL) of the viral inoculum.
The results were expressed as the mean of ﬁve independent
experiments, each with two replicates (n = 20).
2.6. Viral quantitation by reverse transcription, followed
by real-time PCR (RT-qPCR)
The viral genome was quantiﬁed in the collected previously
cell monolayers using real-time RT-PCR according to the
methodology previously described [27]. For this, total RNA was
extracted using the modiﬁed RNAzol method and a total of
0.5 mg of RNA was reverse transcribed using 0.5 mg/mL of
random primers (Promega Corp., Madison, WI, USA) and
200U of M-MLV reverse transcriptase (Promega). The cDNA
was ampliﬁed by real-time PCR (qPCR) using SYBR Green
and DENV-2-speciﬁc primers (mD1 and mTS2). These primers
amplify a 119 bp segment of the C-prM region. Ampliﬁcation
was conducted in a SmartCycler (Chepeid, Sunnyvale, CA,
USA), and the genomic copy amounts were calculated with an
absolute quantitation, using a speciﬁc standard curve for DENV-
2. The results were expressed as the mean of ﬁve independent
experiments (n = 5).
2.7. Protein extraction
The cells obtained from infected and uninfected cultures were
dislodged using 0.25% trypsin, spun at 1500 r/min for 5 min,
and washed twice with PBS. The cells were lysed usinghypotonic PBS (13.6 mmol/L NaCl, 0.27 mmol/L KCl,
0.4 mmol/L Na2HPO4, and 0.15 mmol/L KH2PO4) and sub-
jected to ﬁve freezing (in liquid nitrogen) and thawing (using
ultrasound) cycles. The insoluble material was removed by
centrifugation, and the supernatant was used to precipitate pro-
teins using acetone. The precipitate was resuspended in hydra-
tion buffer (9 mol/L urea, 4% CHAPS, 1.6% 3–10 ampholytes,
1% 4–7 ampholytes, and 40 mmol/L dithiothreitol), and the
protein concentration was determined using a 2D Quant kit (GE
Healthcare, Piscataway, NJ, USA).
2.8. Two-dimensional electrophoresis
A total of 200 mg of protein obtained from each of the
experimental conditions was loaded onto 7-cm DryStrip strips
with a non-linear pH of 3–10 (GE Healthcare) and allowed to
hydrate passively for 12 h. The ﬁrst dimension (isoelectric
focusing) was conducted at 20 C and with a 50 mA current per
strip, using the Ettan IPGphor 3 system (GE Health-care) until
14 800 volt-hours was reached. The strips were equilibrated by
incubating them in buffer I (6 mol/L urea, 2% sodium dodecyl
sulfonate, 375 mmol/L Tris–HCl pH 8.8, 20% glycerol, and
10 mg/mL of dithiothreitol) for 20 min, followed by incubation
in buffer II (6 mol/L urea, 2% sodium dodecyl sulfonate,
375 mmol/L Tris–HCl pH 8.8, 20% glycerol, 25 mg/mL of
iodoacetamide) for 20 min. After equilibration, the strips were
placed on 12.5% acrylamide/bis-acrylamide gels, and the second
dimension was conducted using the Mini-PROTEAN system
(Biorad, Hercules, CA, USA) at 100 V for 90 min. The gels
were stained using the Oriole ﬂuorescent kit (Biorad, Hercules,
CA, USA) for 90 min. A total of 5 gel replicates for each
experimental condition was obtained (n = 5).
2.9. Image analysis and protein expression comparison
Gel images were captured using a ChemiDoc XRS scanner
(Biorad), and the images were analyzed using ImageMaster 2D
Platinum 7.0 software (GE Healthcare). The parameters used to
detect spots were as follows: smooth, 4; saliency, 8; and minimal
area, 3. To determine the spots displaying differential expres-
sion, the relative volume of spots expressed in U937 cells
infected with each of the reference stocks and in uninfected
cultures were compared using the image analysis software.
2.10. Protein digestion and MALDI-TOF/TOF mass
spectrometry
The differentially expressed protein spots were excised from
the gel, washed 3 times with 50% acetonitrile (ACN) and
50 mmol/L ammonium bicarbonate (NH4HCO3) for 10 min, and
dehydrated with 100% ACN for 10 min. Then, 20 mg/mL trypsin
in 25 mmol/L NH4HCO3 was added, and the proteins were
digested overnight at 36 C. The next day, ACN was added for
10 min, and the extracted peptides were dried in a vacuum
centrifuge. After centrifugation, the peptides were resuspended
in a 50% methanol/0.1% triﬂuoroacetic solution, and each
sample was dropped on a MALDI plate containing a matrix
solution (50% alpha-cyano-4-hydroxycinnamic acid in ACN,
0.1% triﬂuoroacetic, 10 mmol/L ammonium citrate). The sam-
ples were analyzed with an ABI 4800 MALDI-TOF/TOF mass
spectrometer (MS), with a mass range of 700–4000 Da. Peptides
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Figure 1. Effect of DENV serotype 2 on cell viability. The values repre-
sent the means of 3 independent experiments, each with 2 replicates for
each condition ± SEM (n = 6).
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for tandem mass spectrometry (MS/MS). MS/MS was conducted
using air as a collision gas and 2 kV collision energy. A
maximum of 45 MS/MS spectra were allowed for each spot.
2.11. Protein identiﬁcation
Protein identiﬁcation based on the obtained MALDI-TOF/
TOF spectra was conducted using GPS Explorer™ protein
analysis 3.6 software (Applied Biosystems, Foster City, CA,
USA). This software conducts a combined search of the MS and
MS/MS data against the non-redundant database of the National
Center of Biotechnology (NCBI nr), using the MASCOT®
search engine (Matrix Science, Boston, MA, USA). Trypsin was
deﬁned as the digesting enzyme, whereas methionine oxidation
and lysine acetylation were deﬁned as peptide modiﬁcations.
Mass tolerances of 80 mg/kg for precursor ions and 0.5 Da for
the corresponding fragments were allowed. The bioinformatics
analysis was conducted by sequence homology of proteins
belonging to Homo sapiens. The biological functions of the
identiﬁed proteins were assigned according to gene ontology,
and the identiﬁed proteins were classiﬁed according to their cell
function.
2.12. Statistical analysis
Student's t-test was used to compare the cell viability be-
tween infected and uninfected cultures. Similarly, this test was
used to compare the number of infectious viral particles and the
number of genomic copies between DENV-2/NG-versus
DENV-2/16681-infected U937 cells. In both cases, P < 0.05
indicated a statistically signiﬁcant difference. For the proteomic
analysis, an ANOVA test was used to compare the level of in-
tensity (volume intensity) for each spot in each condition
(infection with DENV-2/NG, infection with DENV-2/16681 andA B
D E
Figure 2. Effect of DENV serotype 2 on the morphology of U937 cells.
A–C: C6/36HT cells; D–F: U937 cells; A and D: Uninfected cell cultures; B and
with DENV-2/16681. C6/36HT cells were used as a positive control of infectinon-infection). Finally, comparisons with P < 0.05 were further
assessed with Tukey's post-hoc test.
3. Results
3.1. Effect of DENV-2 infection on U937 cell viability
An MTT assay was conducted to determine the effect of virus
infection on cell viability. No signiﬁcant differences were
observed at 48 h post-infection when DENV-2/NG- or DENV-2/
16681-infected U937 cells were compared to the uninfected
control culture (P < 0.05) (Figure 1). DENV-2 infection did not
affect U937 cell viability. Moreover, neither of two viral strains
produced morphological changes in the cells U937 (Figure 2).
Based on these results, subsequent assays were conducted with a
48-h incubation period to guarantee that any proteome changes
were due to viral infection and not due to infection-induced cell
death.C
F
E: Cell cultures infected with DENV-2/NG; C and F: Cell cultures infected
on, and morphological changes were observed in these cells.
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the DENV-2/16681 and DENV-2/NG strains
To compare the infection in the cultures infected with either
DENV-2/NG or DENV-2/16681, RT-qPCR was conducted to
quantify the viral genome (in monolayers). Viral titering by the
plaque method was used to quantify the infectious viral particles
released into the medium (in the supernatant). Signiﬁcant dif-
ferences were observed in the number of genomic copies ob-
tained from DENV-2/NG-infected cells (1.43 × 107 genomic1.0E+10
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Figure 3. Comparison of the viral genome replication rates of the DENV-
2/16681 and DENV-2/NG strains.
Viral production was measured 48 h after cultures were infected with an
MOI of 1. A: Viral genome quantitation measured by RT-qPCR in
monolayers; B: Infectious viral particle quantitation was measured using a
supernatant plaque assay. Signiﬁcant differences were only detected when
the genome copy numbers were compared. The asterisk indicates P < 0.05
(student's t-test). The values represent the means of 3 independent experi-
ments, each with 2 replicates for each condition ± SEM (n = 20).
Figure 4. Comparison of the number of infected cells between cultures
infected with DENV-2/16681 and cultures infected with DENV-2/NG.
A: Uninfected cell cultures; B: Cell cultures infected with DENV-2/NG; C:
Cell cultures infected with DENV-2/16681.copies/mL) compared with the genomic copies from DENV-2/
16681-infected cells (9.01 × 107 genomic copies/mL)
(P < 0.05). Infection was greater in the latter strain (Figure 3A).
On the other hand, no signiﬁcant differences were observed
in the number of infectious viral particles in the supernatant
of DENV-2/NG-infected cells (2.19 × 106 PFU/mL) compared
to DENV-2/16681-infected cells (2.54 × 106 PFU/mL)
(Figure 3B). These results were consistent with the number of
infected cells that was higher in cultures infected with DENV-2/
16681 than those infected with DENV-2/NG (Figure 4).
3.3. DENV-2 infection modiﬁes protein expression in a
strain-dependent manner
To obtain the proteomes, the proteins extracted from infected
and uninfected U937 cell monolayers were separated by two-
dimensional electrophoresis. On average, 189 spots were iden-
tiﬁed in uninfected U937 cells, 156 spots in DENV-2/NG-
infected cells, and 200 in DENV-2/16681-infected cells. The
different proteins detected had isoelectric points (pI) between
four and eight and molecular weights between 11 and 84 kDa.
The differential expression analysis was conducted using the
relative volumes of the expressed spots of the infected versus
uninfected cultures. Only proteins with a differential expression97.0
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Figure 5. Differentially expressed proteins in uninfected cultures (A)
compared with DENV-2/NG-infected cultures (B). A total of 200 mg of
protein was separated by two-dimensional electrophoresis for each sample.
The differentially expressed spots are indicated in the ﬁgures. The squares
indicate proteins with increased expression in infected cultures, and the
circles indicate proteins with decreased expression in infected cultures. A
representative gel of the 5 gels that were analyzed is shown for each bio-
logical condition.
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Figure 6. Differentially expressed proteins in uninfected cultures (A)
compared with DENV-2/16681 infected cultures (B). A total of 200 mg of
protein was separated by two-dimensional electrophoresis for each sample.
The differentially expressed spots are indicated in the ﬁgures. The squares
indicate proteins with increased expression in infected cultures, and the
circles indicate proteins with decreased expression in infected cultures. A
representative gel of the 5 gels that were analyzed is shown for each bio-
logical condition.
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were included. The relative expression change was considered
signiﬁcant if the ANOVA and Tukey's post-hoc tests had P-
values < 0.05.Table 1
Comparison of proteins expressed in uninfected vs. DENV-2/NG-infected cu
Spot
no.
Protein ID NCBI
accession
Molecular
weight
(kDa)
Number of
matched
peptides
Score
&
MS/M
21 Fatty acid-binding
protein
gi|4557581 15.15 9 24
62 hnRNP 1 gi|48145673 49.10 16 32
89 Protein disulﬁde
isomerase
gi|119597640 54.05 17 51
112 Enolase 1 gi|62897945 47.17 22 52
167 Heat shock 70 kDa
protein 9
gi|12653415 73.68 21 60
42 Heat shock 90 kDa
protein AA1
gi|38196932 49.16 14 53
240 Tubulin beta gi|119608775 48.79 14 34
243 Enolase 1 gi|203282367 47.01 24 52
244 Pyruvate kinase M2 gi|169404695 56.52 18 23The protein analysis indicated nine differentially expressed
proteins in DENV-2/NG-infected U937 cells. The expression of
ﬁve of these proteins (Spots 21, 62, 89, 112 and 167) decreased
in the infected cultures and four proteins (Spots 42, 240, 243 and
244) displayed increased expression compared with uninfected
cultures (Figure 5A and B). The main percentage of differential
expression was represented by proteins presenting decreased
expression in the infected cultures (55.5%).
On the other hand, the protein analysis indicated that six
proteins were differentially expressed in DENV-2/16681-
infected U937 cells. The expression of two of these proteins
(Spots 173 and 178) decreased in the infected cultures,
whereas the expression of the remaining four proteins (Spots
150, 152, 189, and 198) increased in the infected cultures
compared to the uninfected ones (Figure 6A and B). The main
percentage of differential expression was represented by pro-
teins displayed increased expression in the infected cultures
(66.6%).
3.4. Protein identiﬁcation by MS
Proteins with differential expression were identiﬁed by
MALDI-TOF/TOF MS. The biological functions of these pro-
teins were assigned according to gene ontology, and the iden-
tiﬁed proteins were classiﬁed into several different categories.
The proteins with decreased expression in DENV-2/NG-
infected cultures compared with the uninfected cultures were
as follows: fatty acid-binding protein (21), heterogeneous nu-
clear ribonucleoprotein 1 (hnRNP 1) (62), protein disulﬁde
isomerase (89), enolase 1 (112) and heat shock 70 kDa protein 9
(167). The proteins that displayed increased expression in the
infected cultures were heat shock 90 kDa protein AA1 (42),
tubulin beta (240), enolase 1 (243) and pyruvate kinase M2
(244) (Table 1).
In DENV-2/16681-infected cultures, the proteins that dis-
played decreased expression were as follows: phosphotyrosyl
phosphatase (173) and annexin IV (178). The proteins that
displayed increased expression were as follows: pyruvate kinase
(150), pyruvate kinase M2 (152), transaldolase (189) and
phospholipase C-alpha (198) (Table 2).ltures.
MS
S
% Cover
sequence
Volume intensity Cell function
Uninfected DENV-2/NG
infected
7 45.19 0.34 0.00 Lipid-binding protein
2 30.07 0.28 0.00 RNA splicing
2 37.50 0.16 0.00 Cell redox homeostasis
2 54.61 0.13 0.00 Carbohydrate metabolism
1 32.99 0.47 0.00 Protein folding
4 24.64 0.29 0.67 Protein folding
5 34.55 0.00 0.30 Cytoskeleton
6 52.66 0.00 0.32 Carbohydrate metabolism
2 48.65 0.00 0.27 Carbohydrate metabolism
Table 2
Comparison of proteins expressed in uninfected vs. DENV-2/16681-infected cultures.
Spot
no.
Protein ID NCBI
accession
Molecular
weight
(kDa)
Number of
matched
peptides
Score MS
&
MS/MS
% Cover
sequence
Volume intensity Cell function
Uninfected DENV-2/16681
infected
173 Phosphotyrosyl
phosphatase
gi|157837067 17.90 10 282 42.04 0.26 0.00 Signal transduction
178 Annexin IV gi|189617 36.03 19 762 57.94 0.52 0.00 Calcium ion binding
150 Pyruvate kinase
(human muscle)
gi|67464392 59.71 32 986 59.12 0.13 0.29 Carbohydrate metabolism
152 Pyruvate kinase M2 gi|169404695 56.52 31 841 62.16 0.13 0.27 Carbohydrate metabolism
189 Transaldolase gi|5803187 37.52 6 92 17.56 0.00 0.10 Carbohydrate metabolism
198 Phospholipase C-alpha gi|303618 56.67 11 190 28.71 0.00 0.20 Signal transduction
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Cells of the monocyte/macrophage lineage are of great
importance during dengue's development because they are one
of the primary targets for DENV, responsible for spreading it
from the site of infection toward different sections of the body
[15]. In addition, once infection has been established, these cells
are the main responsible party for pro-inﬂammatory cytokine
production, thus facilitating the development of severe forms of
the disease [15,18]. Despite the important role that these cells
have on the disease's pathogenesis (in both primary and
secondary infections), to date, there is only one study that
shows how some proteins from the undifferentiated monocyte
cell line THP-1 are affected under primary infection conditions
[28]. Therefore, this study evaluated the proteome changes in the
differentiated monocyte cell line U937 after infection with two
different viral strains, keeping in mind that the viral genetic
variations have been associated with both the epidemic
potential of the infection and disease severity.
Because it has been previously reported that different strains
from the same serotype can promote signiﬁcant changes in both
morphology and viability in cell cultures [27], an initial
comparison was performed on the viability of the non-infected
cell cultures with those infected for 48 h, revealing that
viability was not signiﬁcantly impaired in the infected cultures
(Figure 1), similar to the behaviors found for other cell lines of
epithelial (VERO) or hepatic origin (HepG2) [29,30]. Signiﬁcant
changes in morphology were also not observed (Figure 2). This
result offers assurance that the changes in the cellular proteome
are caused by DENV infection and not cell death.
When performing the comparative analysis of the produc-
tion of viral genome copies and infectious particles from each
viral strain after infecting U937 cells, signiﬁcant differences
were detected only in viral RNA production. The cells infected
with the DENV-2/16681 strain had a higher genomic copy
number than those infected with the DENV-2/NG strain
(Figure 3). This increased replication rate obtained with the
strain associated with severe dengue had been previously re-
ported in the VERO cell line [30] and could be related to the
development of this clinical form of the disease, as some
clinical studies have demonstrated higher levels of viral RNA
in the plasma of patients with severe dengue in comparison
with dengue patients [31]. However, a higher number of cells
were immunolabeled against viral proteins in cultures
infected with DENV-2/16681 (Figure 4), which could be
correlated with the high viral protein levels detected in patients
with severe dengue [32].Previous studies have shown that the proteomes of epithelial
cells (VERO) are signiﬁcantly different when these cells are
infected different viral strains [30]; a similar behavior was
detected in this study when U937 cells were infected with
either the DENV-2/NG (Figure 5 and Table 1) or DENV-2/
16681 strains (Figure 6 and Table 2). The most relevant ﬁnd-
ings will be discussed next.
The fatty acid-binding protein was downregulated in
U937 cells infected with the DENV-2/NG strain. Keeping in
mind that lipids and fatty acids induce the formation of repli-
cation complexes in DENV infection, their downregulation
would be unfavorable for viral replication in this cell type. This
ﬁnding could be related with observations from other studies
showing that the percentage of infected monocytes in vitro are
much lower compared with the percentages obtained from
epithelial, hepatic, and endothelial cell types [33]. However,
keeping in mind that this same protein is upregulated in
VERO cells infected with DENV-2/16681 [30], it could be
surmised that the regulation of its expression could be affected
by the infecting viral strain, which, in turn, could be correlated
with differences in viral genome quantity, which is lower in
cells infected with the DENV-2/NG strain compared with the
DENV-2/16681 strain (Figure 3). Regardless, in the present
study, there was a signiﬁcant increment in the quantity of this
protein in the cultures of monocytes infected with the DENV-2/
1668 strain, which makes it impossible to prove this hypothesis.
Another protein that was downregulated in the cultures
infected with the DENV-2/NG strain was disulﬁde isomerase, a
protein that regulates platelet function and helps to maintain
their structural integrity [34]. For this reason, its decreased
expression could be related to the development of
thrombocytopenia, which is characteristic of dengue [35].
However, decreased levels of this protein have also recently
been detected in a pathologic condition known as
macrothrombocytopenia [36], a ﬁnding that could be associated
with what occurs in dengue infections, as it is known that
platelet function is affected during disease development [37].
These results are also correlated with previous ﬁndings in
VERO cells [30] in which downregulation of this protein was
observed after infection with the DENV-2/16681 strain, which
is related to platelet adhesion inhibition, thus allowing severe
hemorrhage.
One of the isoforms of the enolase protein was upregulated in
cultures infected with the DENV-2/NG strain, while another of
the isoforms was downregulated in the same cultures. These
ﬁndings agree with recent studies that showed increased levels
of basic isoforms of enolase in hepatocytes, although its acid
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protein is not only involved in cytoplasmic processes such as
glycolysis but is also expressed on the surfaces of diverse he-
matopoietic, epithelial and endothelial cells and serves as a re-
ceptor and plasminogen activator [39–41], thus fulﬁlling an
important task in the intravascular coagulation and ﬁbrinolytic
system [41]. It has been proposed that enolase upregulation
during DENV infection could be associated with the
compromised vascular and coagulation systems present during
severe dengue cases. The a-enolase protein could activate
plasminogen, modify the coagulation-ﬁbrinolysis balance and
favor hyperﬁbrinolysis. In fact, several studies have reported
increases in ﬁbrin degradation products during DENV infection
[42]. Enolase downregulation could be correlated with a decrease
in the intracellular viral load due to an increase in the tumor
necrosis factor-a level, a recently proposed mechanism in
THP-1 cells [28].
hnRNP 1 is another of the downregulated proteins detected in
cultures infected with DENV-2/NG. This ﬁnding contrasts with
the results obtained from other groups that have shown that
several isoforms of this protein are upregulated in endothelial
cells infected with the DENV-2/16681 strain or in undifferen-
tiated monocytic cells [28,43]. However, these differences could
be explained considering that, as we previously demonstrated,
the regulation of the expression of certain proteins is
dependent on the cell type analyzed and the infecting viral
strain [30]. However, decreased expression of this protein in
monocytes could prevent the migration of infected cells,
which would limit, eliminate or delay the development of
severe forms of the disease, as it has been reported that this
protein, when interacting with intermediate ﬁlaments, plays an
important role in cellular migration [44].
Heat shock protein 70 kDa (Hsp-70) was upregulated in
VERO cultures infected with DENV-2/16681 [30], and
interestingly, downregulated in U937 cells. Keeping in mind
that cells of epithelial origin replicate the virus more
efﬁciently than monocytes as well as the role that this protein
plays by interacting with the DENV E glycoprotein,
facilitating viral replication and the production of viral
particles [33,45], it could be postulated that its downregulation
prevents the correct folding of viral proteins, making viral
replication more difﬁcult in these cells. In contrast, heat shock
protein 90 kDa (Hsp-90) was upregulated; this protein is also
required for viral replication, as has been previously reported
[46]. Thus, it could be proposed that Hsp-70 downregulation
would be compensated with Hsp-90 upregulation. While Hsp-90
plays a very important role in DENV internalization [20],
suggesting that the capture and internalization of the virus in
macrophages could be made more efﬁcient by Hsp-90 upregu-
lation, and viral replication would be less efﬁcient due to Hsp-70
downregulation.
The only protein identiﬁed in this study whose expression
was increased independent of the infecting viral strain (DENV-
2/NG or DENV-2/16681) was pyruvate kinase. Keeping in mind
that this enzyme is involved in the process of glycolysis for
energy production in the cell, it has been proposed that modi-
ﬁcations in its expression are associated with a higher energy
requirement for DENV replication [30,38].
Infection with DENV-2/NG also increased the expression of
b-tubulin, a cytoskeletal protein. Keeping in mind that it has
been postulated that tubulin (the main component of microtu-
bules) facilitates the trafﬁcking of the DENV E protein [47], itsupregulation could facilitate viral assembly in these cells.
However, its upregulation could also be correlated with a
higher risk of developing severe forms of the disease, as
increased tubulin expression has been detected in patient
serum, an observation that has led to postulations on the
suitability of tubulin as a biomarker for the development of
severe forms of dengue disease [48].
The phosphotyrosyl phosphatase protein was downregulated,
which could be related to an increase in nitric oxide (NO) pro-
duction, as it has been demonstrated that this protein regulates
NO production in macrophages [49]. In turn, the increase in NO
could be considered a cellular defense mechanism, as a
correlation between NO production and the development of
non-severe forms of dengue disease has been reported [50].
Anexin 4 was also downregulated in cultures infected with
the DENV-2/16681 strain. It was recently shown that anexin A4
regulates interleukin 8 (IL-8) production in macrophage cultures.
When anexin is over-expressed in these cultures, IL-8 produc-
tion is signiﬁcantly decreased [51]. For this reason, keeping in
mind that the results obtained in this study demonstrate a
decrease in anexin A4 expression in cultures infected with the
DENV-2/16681 strain, it would be postulated that this down-
regulation could lead to increased IL-8 expression. In turn, the
increase in IL-8 has been associated with the development of
severe forms of dengue disease, as higher levels of IL-8 have
been detected in patients with severe dengue [52].
Transaldolase protein expression was increased in cultures
infected with the DENV-2/16681 strain. This enzyme partici-
pates in the phosphate pentose pathway, which allows the pro-
duction of ribose 5-phosphate, an important precursor in
nucleotide synthesis required for RNA replication [53]. Thus, it is
postulated that the increase in the expression of this enzyme may
be associated with a higher replication rate of the DENV-2/
16681 strain, which is correlated with the increase in the
genome copy number of this strain (Figure 3A).
Finally, DENV-2/16681 infection also caused an increase in
the expression of the phospholipase C protein, an enzyme that
can cleave the viral non-structural protein 1 (NS1) on the sur-
faces of cells infected with DENV [54]. NS1 can be detected
intracellularly, associated with the plasma membrane or in
secreted form [55], the last of which is associated with the
development of severe dengue, as the secreted NS1 protein
can bind to prothrombin (a coagulation factor) and inhibit its
activation, thus avoiding the development of a normal
coagulation process and favoring hemorrhage [56]. Therefore, it
is suggested that the upregulation of phospholipase C
expression could induce an increase in the NS1 levels in
patient serum and thereby contribute to the hemorrhagic
symptoms characteristic of severe dengue.
This proteomic study identiﬁed changes in the expression
levels of proteins in differentiated human monocytes in response
to infection with two DENV strains. These proteins are involved
in many biological processes, which may beneﬁt viral replica-
tion or, alternatively, be related to disease development. Because
monocytes are critical for the disease pathogenesis, additional
studies on these proteins could lead to a better understanding of
the cellular responses to DENV infection and to the identiﬁca-
tion of new therapeutic targets against this disease.
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